Chest-oscillation airway secretion-clearing system

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Koop het nu

Beschikbaar vanaf:

MGC Diagnostics Australia Pty Ltd

klasse:

Class IIa

Geproduceerd door:

Respinnovation SAS 611 Chemin de l'Ardrech, Seillans, 83440 France

Therapeutisch gebied:

38124 - Chest-oscillation airway secretion-clearing system

therapeutische indicaties:

The RespIn 11 is intended to provide bronchial clearance therapy when external manipulation of the thorax is the physician's choice of treatment. Indications for this form of therapy are described by the American Association for Respiratory Care (AARC) in the Clinical Practices Guidelines for Postural Drainage Therapy' (1991). According to AARC guidelines, specific indications for external manipulation of the thorax include evidence or a suggestion of retained secretions, evidence that the patient is having difficulty with secretion clearance, or presence of atelectasis caused by mucus plugging. In addition, the RespIn 11 is also indicated for external manipulation of the thorax to promote bronchial clearance or improve bronchial drainage for purposes of collecting mucus for diagnostic evaluation

Autorisatie-status:

A

Autorisatie datum:

2019-08-22

Zoekwaarschuwingen met betrekking tot dit product